Association of Medical Microbiology and Infectious Disease Canada

Last updated
Association of Medical Microbiology and Infectious Disease Canada
PredecessorThe Canadian Association of Medical Microbiology (CAMM) and the Canadian Infectious Diseases Society (CIDS) [1]
Founded2004
TypeNon-profit professional association
Focus Medical Microbiology and Infectious Diseases
Headquarters192 Bank Street
Ottawa, Ontario
K2P 1W8
Area served
Canada
Key people
Todd Hatchet (President)
Sarah Forgie (President-Elect)
Caroline Quach-Thanh (Past-President)
Website ammi.ca

The Association of Medical Microbiology and Infectious Disease Canada (AMMI Canada) is a Canadian national medical specialty association composed of specialists in infectious diseases and medical microbiology, clinical microbiologists and researchers specializing in preventing, diagnosing, and treating infections. The association is a national specialty society recognized by the Royal College of Physicians and Surgeons of Canada. [2] The association promotes the prevention, diagnosis, and treatment of human infectious diseases through our involvement in education, research, clinical practice and patient advocacy. Position papers [3] and guidelines [4] [5] [6] in support of this mission are published in the official Journal of the Association of Medical Microbiology and Infectious Diseases - JAMMI [7] (an open access journal) and/or posted on the organization's website. [8] Prior to January 1, 2016, these were published in the Canadian Journal of Infectious Diseases and Medical Microbiology [9] The annual meeting of the association occurs in the spring at which members present information of mutual interest.[ citation needed ]

Contents

History

AMMI Canada was formed in 2004 with the merger between the Canadian Association of Medical Microbiology (CAMM) and the Canadian Infectious Diseases Society (CIDS). CAMM was incorporated under the Companies Act in 1961 under the name of the Canadian Association of Medical Bacteriologists while CIDS was formed in 1977. [10] The organizations formed in recognition of the similar "activities, interests, and goals for infectious diseases and medical microbiology specialists." [10]

Governance

AMMI Canada is governed by a Council composed of thirteen members: the President, President-Elect, Past President, Treasurer, Secretary, Medical Microbiology Section Chair, Infectious Disease Section Chair, and six Members of Council. [11] The council also has three ex-officio members.[ citation needed ]

AMMI Canada's vision is: "Fewer infections. Fewer outbreaks. Healthy Canadians" and its mission is to "advance the prevention, diagnosis, and treatment of infections." [12] AMMI Canada's strategic planning goals and initiatives are defined in six areas. These are: antimicrobial stewardship and resistance, infection prevention and control, education and knowledge translation, advocacy, human health resources planning and research. Specific details are available on the Association website. [12]

Partnerships

The association collaborates with the Canadian Foundation for Infectious Diseases in raising money to support infectious diseases research in support of its mission. [13] Corporate partners of the CFID include AbbVie, BD, BioMérieux, Gilead Sciences, KPMG, Merck, and Sunovion. [14]

Education

AMMI Canada's principal event is the AMMI Canada-CACMID Annual Conference, jointly hosted with the Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID). [15] [16] The conference typically takes place in April, and has been hosted in cities such as Charlottetown, PEI (2015), [16] Victoria, BC (2014), Québec City, QC (2013), Vancouver, BC (2012), Montréal, QC (2011), and Edmonton, AB (2010). [17] The 2016 meeting was held in Vancouver. Abstracts of the meeting are available in the official journal. [18]

The AMMI Canada-CACMID Annual Conference is host to the awards and student awards presentations, where AMMI Canada's Distinguished Service Award, Lifetime Achievement Award, Honorary Membership, and Residency Fellowships are presented. [19] The Annual Conference is also where other organizations, such as CACMID, [20] the Canadian College of Microbiologists, [21] and the Canadian Foundation for Infectious Diseases [22] present their awards.

Attendees of the Annual Conference can also obtain Continuing Education Credits. [23]

In addition to the organization's joint conference, AMMI Canada also collaborated with the Canadian Paediatric Society for co-developed learning opportunities at the 2014 Canadian Immunization Conference held in December 2014. [24]

Related Research Articles

<span class="mw-page-title-main">Tuberculosis</span> Infectious disease

Tuberculosis (TB), also known colloquially as the "white death", or historically as consumption, is an infectious disease usually caused by Mycobacterium tuberculosis (MTB) bacteria. Tuberculosis generally affects the lungs, but it can also affect other parts of the body. Most infections show no symptoms, in which case it is known as latent tuberculosis. Around 10% of latent infections progress to active disease which, if left untreated, kill about half of those affected. Typical symptoms of active TB are chronic cough with blood-containing mucus, fever, night sweats, and weight loss. Infection of other organs can cause a wide range of symptoms.

<span class="mw-page-title-main">Herd immunity</span> Concept in epidemiology

Herd immunity is a form of indirect protection that applies only to contagious diseases. It occurs when a sufficient percentage of a population has become immune to an infection, whether through previous infections or vaccination, thereby reducing the likelihood of infection for individuals who lack immunity.

<i>Shigella</i> Genus of bacteria

Shigella is a genus of bacteria that is Gram-negative, facultatively anaerobic, non–spore-forming, nonmotile, rod-shaped, and is genetically closely related to Escherichia. The genus is named after Kiyoshi Shiga, who discovered it in 1897.

<span class="mw-page-title-main">Whooping cough</span> Human disease caused by the bacteria Bordetella pertussis

Whooping cough, also known as pertussis or the 100-day cough, is a highly contagious, vaccine-preventable bacterial disease. Initial symptoms are usually similar to those of the common cold with a runny nose, fever, and mild cough, but these are followed by two or three months of severe coughing fits. Following a fit of coughing, a high-pitched whoop sound or gasp may occur as the person breathes in. The violent coughing may last for 10 or more weeks, hence the phrase "100-day cough". The cough may be so hard that it causes vomiting, rib fractures, and fatigue. Children less than one year old may have little or no cough and instead have periods where they cannot breathe. The incubation period is usually seven to ten days. Disease may occur in those who have been vaccinated, but symptoms are typically milder.

<span class="mw-page-title-main">Varicella zoster virus</span> Herpes virus that causes chickenpox and shingles

Varicella zoster virus (VZV), also known as human herpesvirus 3 or Human alphaherpesvirus 3 (taxonomically), is one of nine known herpes viruses that can infect humans. It causes chickenpox (varicella) commonly affecting children and young adults, and shingles in adults but rarely in children. As a late complication of VZV infection, Ramsay Hunt syndrome type 2 may develop in rare cases. VZV infections are species-specific to humans. The virus can survive in external environments for a few hours.

<span class="mw-page-title-main">American Society for Microbiology</span> American scholarly society focused on microbiology

The American Society for Microbiology (ASM), originally the Society of American Bacteriologists, is a professional organization for scientists who study viruses, bacteria, fungi, algae, and protozoa as well as other aspects of microbiology. It was founded in 1899. The Society publishes a variety of scientific journals, textbooks, and other educational materials related to microbiology and infectious diseases. ASM organizes annual meetings, as well as workshops and professional development opportunities for its members.

<span class="mw-page-title-main">Mycoplasmataceae</span> Family of bacteria

Mycoplasmataceae is a family of bacteria in the order Mycoplasmatales. This family consists of the genera Mycoplasma and Ureaplasma.

<span class="mw-page-title-main">Medical microbiology</span> Branch of medical science

Medical microbiology, the large subset of microbiology that is applied to medicine, is a branch of medical science concerned with the prevention, diagnosis and treatment of infectious diseases. In addition, this field of science studies various clinical applications of microbes for the improvement of health. There are four kinds of microorganisms that cause infectious disease: bacteria, fungi, parasites and viruses, and one type of infectious protein called prion.

<span class="mw-page-title-main">Pathogenic bacteria</span> Disease-causing bacteria

Pathogenic bacteria are bacteria that can cause disease. This article focuses on the bacteria that are pathogenic to humans. Most species of bacteria are harmless and are often beneficial but others can cause infectious diseases. The number of these pathogenic species in humans is estimated to be fewer than a hundred. By contrast, several thousand species are part of the gut flora present in the digestive tract.

Anita Rachlis, M.D. is a Canadian HIV/AIDS researcher and is the principal author of the HIV treatment guidelines in Canada. She is an associate scientist at the Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, in Toronto, Ontario, Canada.

Allan R. Ronald is a Canadian doctor and microbiologist. He has been instrumental in the investigation into sexually transmitted infections in Africa, particularly in the fields of HIV/AIDS. Ronald is the recipient of multiple awards and honours.

<i>Clostridioides difficile</i> Species of bacteria

Clostridioides difficile is a bacterium known for causing serious diarrheal infections, and may also cause colon cancer. It is known also as C. difficile, or C. diff, and is a Gram-positive species of spore-forming bacteria. Clostridioides spp. are anaerobic, motile bacteria, ubiquitous in nature and especially prevalent in soil. Its vegetative cells are rod-shaped, pleomorphic, and occur in pairs or short chains. Under the microscope, they appear as long, irregular cells with a bulge at their terminal ends. Under Gram staining, C. difficile cells are Gram-positive and show optimum growth on blood agar at human body temperatures in the absence of oxygen. C. difficile is catalase- and superoxide dismutase-negative, and produces up to three types of toxins: enterotoxin A, cytotoxin B and Clostridioides difficile transferase. Under stress conditions, the bacteria produce spores that are able to tolerate extreme conditions that the active bacteria cannot tolerate.

<span class="mw-page-title-main">Elizabeth O. King</span> American bacteriologist (1912–1966)

Elizabeth Osborne King was an American microbiologist who discovered and described bacteria of medical importance at the United States Centers for Disease Control and Prevention from the late 1940s through the early 1960s. A 1984 CDC manual dedication referred to King as "internationally known as an authority on a variety of unusual bacteria." The genera Kingella and Elizabethkingia and several species of bacteria are named to honor her for her pioneering work. King died of cancer on April 8, 1966, in Atlanta, where she is interred in Oakland Cemetery.

The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) is a non-profit international organization with headquarters in Basel, Switzerland. An important activity of the society is the organization of the annual scientific congress ESCMID Global.

<span class="mw-page-title-main">Samir Kumar Saha</span> Bangladeshi Scientist

Samir Kumar Saha is an eminent Bangladeshi microbiologist and public health expert. He is the professor, senior consultant and head of the department of Diagnostic Division of Microbiology at the Dhaka Shishu Hospital for children and also the executive director of The Child Health Research Foundation (CHRF) at the Bangladesh Institute of Child Health.

Allison Joan McGeer is a Canadian infectious disease specialist in the Sinai Health System, and a professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. She also appointed at the Dalla Lana School of Public Health and a Senior Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute, and is a partner of the National Collaborating Centre for Infectious Diseases. McGeer has led investigations into the severe acute respiratory syndrome outbreak in Toronto and worked alongside Donald Low. During the COVID-19 pandemic, McGeer has studied how SARS-CoV-2 survives in the air and has served on several provincial committees advising aspects of the Government of Ontario's pandemic response.

<span class="mw-page-title-main">Robin Patel</span> Canadian microbiologist

Robin Patel is a Canadian born microbiologist and Elizabeth P. and Robert E. Allen Professor of Individualized Medicine, a Professor of Microbiology, and a Professor of Medicine at the Mayo Clinic. She is widely recognized as a leader in the field of clinical microbiology and has held a variety of leadership positions including 2019–2020 President of the American Society for Microbiology (ASM) and Director of the Antibacterial Resistance Leadership Group (ARLG) Laboratory Center of the National institutes of Health. She is currently the Vice Chair of Education in the Department of Laboratory Medicine and Pathology at the Mayo Clinic, and Director of the Mayo Clinic's Infectious Diseases Research Laboratory, where she studies biofilms, antimicrobial resistance, periprosthetic joint infection and diagnostic testing of bacteria.

<span class="mw-page-title-main">Caroline Quach-Thanh</span> Canadian pediatric microbiologist, epidemiologist and infectious diseases specialist

Caroline Quach-Thanh is a Canadian pediatric microbiologist, epidemiologist and infectious diseases specialist. She is a professor in the Université de Montréal Faculty of Medicine and Medical Lead in the Infection Prevention and Control Unit at CHU Sainte-Justine. She served as the Chair of the National Advisory Committee on Immunization (NACI) before and during the COVID-19 pandemic, and oversaw the approval process of COVID-19 vaccines in Canada.

Albert Balows was an American clinical microbiologist. He was the president of the American Society for Microbiology in 1981.

Janet Gilsdorf is an American pediatric infectious diseases physician, scientist, and writer at the University of Michigan. Her research has focused on the pathogenic, molecular, and epidemiologic features of the bacterium Haemophilus influenzae. She served as the Director of the Division of Pediatric Infectious Diseases in the University of Michigan Health System from 1989 to 2012 and Co-Director of the Center for Molecular and Clinical Epidemiology of Infectious Diseases at the School of Public Health at the University of Michigan from 2000 – 2015. In addition to her scientific publications, she is also the author of two novels, one memoir, one non-fiction book, and a number of medically-oriented essays.

References

  1. Joffe, A. Mark. "2012 Annual Report" (PDF). AMMI Canada. p. 5. Archived from the original (PDF) on 9 October 2015. Retrieved 26 August 2015.
  2. "National Specialty Societies". Royal College of Physicians and Surgeons of Canada. Archived from the original on 1 July 2014. Retrieved 30 June 2014.
  3. Bow, EJ; Evans, G; Fuller, J; Laverdière, M; Rotstein, C; Rennie, R; Shafran, SD; Sheppard, D; Carle, S; Phillips, P; Vinh, DC (Winter 2010). "Canadian clinical practice guidelines for invasive candidiasis in adults". The Canadian Journal of Infectious Diseases & Medical Microbiology. 21 (4): e122–50. doi: 10.1155/2010/357076 . PMC   3009581 . PMID   22132006.
  4. Bryce, E; Embree, J; Evans, G; Johnston, L; Katz, K; McGeer, A; Moore, D; Roth, V; Simor, A; Suh, K; Vearncombe, M (Winter 2012). "AMMI Canada position paper: 2012 Mandatory influenza immunization of health care workers". The Canadian Journal of Infectious Diseases & Medical Microbiology. 23 (4): e93–5. doi: 10.1155/2012/756824 . PMC   3597405 . PMID   24294284.
  5. Aoki, FY; Allen, UD; Stiver, HG; Evans, GA (Winter 2012). "The use of antiviral drugs for influenza: Guidance for practitioners 2012/2013". The Canadian Journal of Infectious Diseases & Medical Microbiology. 23 (4): e79–92. doi: 10.1155/2012/879141 . PMC   3597404 . PMID   24294283.
  6. Chow, AW; Evans, GA; Nathens, AB; Ball, CG; Hansen, G; Harding, GK; Kirkpatrick, AW; Weiss, K; Zhanel, GG (Spring 2010). "Canadian practice guidelines for surgical intra-abdominal infections". The Canadian Journal of Infectious Diseases & Medical Microbiology. 21 (1): 11–37. doi: 10.1155/2010/580340 . PMC   2852280 . PMID   21358883.
  7. "Home". jammi.utpjournals.press.
  8. "Guidelines". AMMI Canada. Archived from the original on 10 September 2015. Retrieved 26 August 2015.
  9. Kalina, RB; Guerzoni, P; Cavalieri, C; Moretti, M; Marchioni, CF (Fall 2010). "A new publishing model for The Canadian Journal of Infectious Diseases & Medical Microbiology". The Canadian Journal of Infectious Diseases & Medical Microbiology. 21 (3): 109. doi: 10.1155/2010/493694 . PMC   2951797 . PMID   21886645.
  10. 1 2 Nicolle, Lindsay E. (Sep–Oct 2002). "A New Society". The Canadian Journal of Infectious Diseases & Medical Microbiology. 13 (5): 280–281. doi: 10.1155/2002/137892 . PMC   2094887 . PMID   18159401.
  11. "Council". AMMI Canada. Archived from the original on 10 September 2015. Retrieved 26 August 2015.
  12. 1 2 "About AMMI Canada". AMMI Canada. Archived from the original on 2015-02-03. Retrieved 29 Jan 2015.
  13. "Canadian Foundation for Infectious Diseases (CFID)". Association of Medical Microbiology and Infectious Disease Canada. Archived from the original on 2022-03-22. Retrieved 2022-03-22.
  14. "Partners and Supporters". Canadian Foundation for Infectious Diseases. Archived from the original on 2022-01-08. Retrieved 2022-03-22.
  15. "CACMID – AMMI Canada 2015 Annual Conference (Charlottetown)". Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID). Archived from the original on 28 January 2015. Retrieved 30 Jan 2015.
  16. 1 2 "AMMI Canada – CACMID Annual Conference 2015". AMMI Canada. Archived from the original on 4 July 2014. Retrieved 30 Jan 2015.
  17. "Research Conferences". ProvLab Alberta. Archived from the original on 22 September 2015. Retrieved 30 Jan 2015.
  18. "AMMI Canada – CACMID Annual Conference 2016 Abstracts". Pulsus Group INc. March–April 2016. Retrieved 2016-04-26.[ permanent dead link ]
  19. "Grants and Awards". AMMI Canada. Archived from the original on 10 September 2015. Retrieved 26 August 2015.
  20. "Award Winners". CACMID. Archived from the original on 9 September 2015. Retrieved 30 Jan 2015.
  21. "Awards". Canadian College of Microbiologists. Archived from the original on 12 November 2016. Retrieved 27 November 2016.
  22. "CFID Undergraduate Summer Research Awards". Canadian Foundation for Infectious Diseases. Archived from the original on 19 February 2015. Retrieved 30 Jan 2015.
  23. "Continuing Education Credits". Canadian College of Microbiolgists. Archived from the original on 2014-10-10. Retrieved 30 Jan 2015.
  24. "Co-Developed Learning Opportunities". Canadian Immunization Conference. Archived from the original on 2014-10-12. Retrieved 30 Jan 2015.